心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

《中国肺动脉高压诊断与治疗指南（2021版）》解读——聚焦先天性心脏病相关肺动脉高压

2021-10-01 首都医科大学附属北京安贞医院小儿心脏中心 中国实用内科杂志

肺动脉高压

文章是对《中国肺动脉高压诊断与治疗指南(2021版)》中先天性心脏病相关肺动脉高压(CHD-PAH)部分的解读,旨在推动CHD-PAH的规范诊疗,以改善患者预后。

中文标题：

《中国肺动脉高压诊断与治疗指南（2021版）》解读——聚焦先天性心脏病相关肺动脉高压

发布机构：

首都医科大学附属北京安贞医院小儿心脏中心

发布日期：

2021-10-01

简要介绍：

文章是对《中国肺动脉高压诊断与治疗指南(2021版)》中先天性心脏病相关肺动脉高压(CHD-PAH)部分的解读,旨在推动CHD-PAH的规范诊疗,以改善患者预后。我国CHD-PAH患者基数大,疾病谱复杂。针对合并肺动脉高压的先天性心脏病,需要更加规范的手术前评估和手术适应证的判断。加强术后PAH患者随访管理,进行规范化治疗。艾森曼格综合征患者经过有效的药物治疗,也可改善生活质量,避免恶化,但对终末期肺血管疾病患者,心肺移植是最后的治疗手段。然而,目前还缺乏专门针对艾森曼格综合征患者的危险度分层和治疗管理策略。 

相关资料下载：
[AttachmentFileName(sort=1, fileName=《中国肺动脉高压诊断与治疗指南（2021版）》解读——聚焦先天性心脏病相关肺动脉高压.pdf)] GetToolGuiderByIdResponse(projectId=1, id=318a71c002352e8e, title=《中国肺动脉高压诊断与治疗指南（2021版）》解读——聚焦先天性心脏病相关肺动脉高压, enTitle=, guiderFrom=中国实用内科杂志, authorId=0, author=, summary=文章是对《中国肺动脉高压诊断与治疗指南(2021版)》中先天性心脏病相关肺动脉高压(CHD-PAH)部分的解读,旨在推动CHD-PAH的规范诊疗,以改善患者预后。, cover=https://img.medsci.cn/2022212/1644595722228_5579292.jpg, journalId=0, articlesId=null, associationId=2404, associationName=首都医科大学附属北京安贞医院小儿心脏中心, associationIntro=首都医科大学附属北京安贞医院小儿心脏中心, copyright=0, guiderPublishedTime=Fri Oct 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">文章是对《中国肺动脉高压诊断与治疗指南(2021版)》中先天性心脏病相关肺动脉高压(CHD-PAH)部分的解读,旨在推动CHD-PAH的规范诊疗,以改善患者预后。我国CHD-PAH患者基数大,疾病谱复杂。针对合并肺动脉高压的先天性心脏病,需要更加规范的手术前评估和手术适应证的判断。加强术后PAH患者随访管理,进行规范化治疗。艾森曼格综合征患者经过有效的药物治疗,也可改善生活质量,避免恶化,但对终末期肺血管疾病患者,心肺移植是最后的治疗手段。然而,目前还缺乏专门针对艾森曼格综合征患者的危险度分层和治疗管理策略。&nbsp;</span></p>, tagList=[TagDto(tagId=1179, tagName=肺动脉高压)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3733, appHits=164, showAppHits=0, pcHits=557, showPcHits=3568, likes=0, shares=13, comments=6, approvalStatus=1, publishedTime=Sat Feb 12 15:07:00 CST 2022, publishedTimeString=2021-10-01, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Feb 12 00:10:15 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 13:29:40 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=《中国肺动脉高压诊断与治疗指南（2021版）》解读——聚焦先天性心脏病相关肺动脉高压.pdf)])
《中国肺动脉高压诊断与治疗指南（2021版）》解读——聚焦先天性心脏病相关肺动脉高压.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1196017, encodeId=7427119601ed2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbef5482049, createdName=ms9000000107687138, createdTime=Tue Feb 22 11:46:50 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195234, encodeId=790611952344d, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/222b6ed7bdd64216be9d2d7516514243/13f8661159b0443ab25832100f70b55d.jpg, createdBy=e5885495831, createdName=zenger1023, createdTime=Sat Feb 19 23:21:07 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193877, encodeId=79a511938e7f6, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Wed Feb 16 08:50:01 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192842, encodeId=d5b511928422d, content=肺动脉高压，预后不好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2b82397018, createdName=12346c4dm64暂无昵称, createdTime=Sun Feb 13 00:06:10 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192738, encodeId=92411192e38a6, content=实用，, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 19:53:42 CST 2022, time=2022-02-12, status=1, ipAttribution=)]
    2022-02-22 ms9000000107687138

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1196017, encodeId=7427119601ed2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbef5482049, createdName=ms9000000107687138, createdTime=Tue Feb 22 11:46:50 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195234, encodeId=790611952344d, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/222b6ed7bdd64216be9d2d7516514243/13f8661159b0443ab25832100f70b55d.jpg, createdBy=e5885495831, createdName=zenger1023, createdTime=Sat Feb 19 23:21:07 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193877, encodeId=79a511938e7f6, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Wed Feb 16 08:50:01 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192842, encodeId=d5b511928422d, content=肺动脉高压，预后不好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2b82397018, createdName=12346c4dm64暂无昵称, createdTime=Sun Feb 13 00:06:10 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192738, encodeId=92411192e38a6, content=实用，, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 19:53:42 CST 2022, time=2022-02-12, status=1, ipAttribution=)]
    2022-02-19 zenger1023

    很好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1196017, encodeId=7427119601ed2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbef5482049, createdName=ms9000000107687138, createdTime=Tue Feb 22 11:46:50 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195234, encodeId=790611952344d, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/222b6ed7bdd64216be9d2d7516514243/13f8661159b0443ab25832100f70b55d.jpg, createdBy=e5885495831, createdName=zenger1023, createdTime=Sat Feb 19 23:21:07 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193877, encodeId=79a511938e7f6, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Wed Feb 16 08:50:01 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192842, encodeId=d5b511928422d, content=肺动脉高压，预后不好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2b82397018, createdName=12346c4dm64暂无昵称, createdTime=Sun Feb 13 00:06:10 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192738, encodeId=92411192e38a6, content=实用，, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 19:53:42 CST 2022, time=2022-02-12, status=1, ipAttribution=)]
    2022-02-16 龙珠

    学习好资料

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1196017, encodeId=7427119601ed2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbef5482049, createdName=ms9000000107687138, createdTime=Tue Feb 22 11:46:50 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195234, encodeId=790611952344d, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/222b6ed7bdd64216be9d2d7516514243/13f8661159b0443ab25832100f70b55d.jpg, createdBy=e5885495831, createdName=zenger1023, createdTime=Sat Feb 19 23:21:07 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193877, encodeId=79a511938e7f6, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Wed Feb 16 08:50:01 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192842, encodeId=d5b511928422d, content=肺动脉高压，预后不好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2b82397018, createdName=12346c4dm64暂无昵称, createdTime=Sun Feb 13 00:06:10 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192738, encodeId=92411192e38a6, content=实用，, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 19:53:42 CST 2022, time=2022-02-12, status=1, ipAttribution=)]
    2022-02-13 12346c4dm64暂无昵称

    肺动脉高压，预后不好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1196017, encodeId=7427119601ed2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbef5482049, createdName=ms9000000107687138, createdTime=Tue Feb 22 11:46:50 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195234, encodeId=790611952344d, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/222b6ed7bdd64216be9d2d7516514243/13f8661159b0443ab25832100f70b55d.jpg, createdBy=e5885495831, createdName=zenger1023, createdTime=Sat Feb 19 23:21:07 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193877, encodeId=79a511938e7f6, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Wed Feb 16 08:50:01 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192842, encodeId=d5b511928422d, content=肺动脉高压，预后不好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2b82397018, createdName=12346c4dm64暂无昵称, createdTime=Sun Feb 13 00:06:10 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192738, encodeId=92411192e38a6, content=实用，, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 19:53:42 CST 2022, time=2022-02-12, status=1, ipAttribution=)]
    2022-02-12 ms3000000637975859

    实用，

    0

相关指南

治疗儿科动脉性肺动脉高压药物临床试验技术指导原则

国家药品监督管理局药品审评中心（CDE） · 2022-01-12

治疗动脉性肺动脉高压药物临床试验技术指导原则

国家药品监督管理局药品审评中心（CDE） · 2022-01-12

《中国肺动脉高压诊断与治疗指南（2021版）》解读——肺部疾病和（或）低氧所致肺动脉高压

暂未更新 · 2022-01-01

2020 KSC/KATRD指南：肺动脉高压的诊断和治疗（概要）

韩国心脏学会(KSC,Korean Society of Cardiology) · 2021-06-04

中国肺动脉高压诊断与治疗指南(2021版)

中华医学会呼吸病学分会 肺栓塞与肺血管病学组 · 2021-01-05

治疗儿科动脉性肺动脉高压药物临床试验技术指导原则（征求意见稿）

国家药品监督管理局药品审评中心（CDE） · 2021-08-22